Filing Flows

Filing Flows › Medtronic (MDT) › Who owns the stock

Who owns Medtronic (MDT) stock

0 funds reported Medtronic (MDT) shares in their latest 13F filings. Members of Congress and other officials disclosed 8 trades (2 buys, 6 sales).

Trades by Congress and other officials

DateWhoTradeAmount
2026-08-24Kevin Hernsale$15K–$50K
2026-07-30Richard Dean Dr McCormicksale$1K–$15K
2026-05-15Gilbert Cisnerospartial sale$1K–$15K
2026-03-27Alan Armstrongpurchase$1K–$15K
2026-03-20Kevin Hernsale$15K–$50K
2025-12-18Julie Johnsonsale$1K–$15K
2025-11-13Julie Johnsonpartial sale$1K–$15K
2025-11-05Richard Dean Dr McCormickpurchase$1K–$15K

Medtronic's latest quarter

Medtronic, Q1 FY27: revenue $9.8B (+14% year over year), operating margin 18.1%, net earnings $1.5B, operating cash flow $1.8B. The chart follows the revenue to costs, profit and cash.

Questions

Has Congress traded MDT stock?

Officials disclosed 8 trades on file: 2 buys and 6 sales. The latest: Kevin Hern, sale on 2026-08-24.

What is the short interest in MDT?

139,004,337 shares were sold short at the 2026-10-15 settlement, 247.73% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.